ThreeD Capital Inc. ("ThreeD" or the "Company") (CSE:IDK / OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies ...
Inomin Mines Inc. (TSXV: MINE) ("Inomin" or the "Company") is pleased to announce that it has closed its previously announced non-brokered ...
Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug ...
JINAN, China, May 30, 2026 /PRNewswire/ -- From May 25 to 29, 2026, the 7th China-CEEC Local Leaders' Meeting and 2026 Shandong International Friendship Cities Cooperation and Exchange Week, hosted by ...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LRMolecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech ...
Universal Music Group N.V. (UMG.AS, UNVGY, UMGNF), the Dutch-American music-based entertainment company, announced that its Board of Directors has unanimously determined that ...
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul ...
MANAGEMENT REPORT Nordic Fibreboard AS consolidated net revenue in Q1 2026 was €1.86 million, representing a 7.3% increase compared to the same period of the previous year (Q1 2025: €1.74 million), re ...
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced detailed results from the pivotal Phase 3 TALAPRO-3 study evaluating TALZENNA (talazoparib), an oral PARP inhibitor, in combination with XTANDI ...
K92 Mining Inc. ("K92" or the "Company") (TSX: KNT; OTCQX: KNTNF) is pleased to announce the voting results of its 2026 annual general meeting ...
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi /Minjuvi) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously ...
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 29, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech", "Kane" or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results